Activities
Exploring the Clinical Benefits of Antiviral Therapies to Improve Patient Outcomes and Reduce Influenza-Related Complications
0290-0000-20-221-H01-P
This activity will highlight the role that pharmacists can play by being familiar with the medications used in the prevention and treatment of influenza, including their place in therapy, adverse effect profile, and considerations for patient education to provide optimal care.
0.75
Identifying and Managing Immune-Related Adverse Effects Associated With Immune Checkpoint Inhibitor Therapies
0290-0000-20-211-H05-P
This webinar will examine the role of the immune system in fighting cancer and the development of immuno-oncology agents for the treatment of several types of cancer.
1.00
Understanding the Progression of Multiple Sclerosis
0290-0000-20-190-H01-P
This first module in a 3-part series will establish underlying factors for disease progression, the various phases, and goals of treatment to improve the quality of life of patients with MS.
1.00
Multiple Sclerosis: Identifying Appropriate Treatment Options and What's on the Horizon
0290-0000-20-212-H01-P
This second module in a 3-part series will review developing, currently approved, and pipeline agents as well as indications for use of available treatment options in various MS stages.
1.50